XML 69 R24.htm IDEA: XBRL DOCUMENT
v3.23.3

Insider Trading Arrangements | 3 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2023 shares | Sep. 30, 2023 shares
Trading Arrangements, by Individual |  |
Material Terms of Trading Arrangement |  | During the quarter ended September 30, 2023, the following directors and officers (as defined in Exchange Act Rule 16a-1(f)) adopted certain trading plans intended to satisfy Rule 10b5-1(c):
Name |  | Title |  | Adoption or Termination Date |  | Plan Start Date |  | Plan End Date |  | Shares Vesting and Subject to Sell-To-Cover (1) |  | Other Shares Being Sold (Subject to Certain Conditions)
Mauro Ferrari |  | Board Member |  | 09/28/2023 |  | 01/11/2024 |  | 01/31/2024 |  | n/a |  | 3,147
Douglass Given |  | Board Member |  | 09/26/2023 |  | 01/11/2024 |  | 01/31/2024 |  | n/a |  | 2,911
James Hamilton (2) |  | Chief Discovery and Translational Medicine |  | 08/15/2023 |  | 01/03/2024 |  | 01/31/2024 |  | 52,500 |  | n/a
James Hamilton |  | Chief Discovery and Translational Medicine |  | 08/22/2023 |  | 12/01/2023 |  | 11/29/2024 |  | n/a |  | 35,000
Ken Myszkowski |  | Chief Financial Officer |  | 09/07/2023 |  | 01/05/2024 |  | 01/31/2024 |  | 30,000 |  | n/a
Patrick O’Brien |  | Chief Operating Officer and General Counsel |  | 09/03/2023 |  | 01/03/2024 |  | 01/05/2024 |  | n/a |  | 4,000
Tracie Oliver |  | Chief Commercial Officer |  | 08/28/2023 |  | 01/05/2024 |  | 07/31/2024 |  | 17,625 |  | n/a
Victoria Vakiener |  | Board Member |  | 09/28/2023 |  | 01/11/2024 |  | 05/31/2024 |  | n/a |  | 6,519
William Waddill |  | Board Member |  | 08/29/2023 |  | 01/11/2024 |  | 01/31/2024 |  | n/a |  | 3,934
(1) This column indicates the total number of shares vesting, but the 10b5-1 Plan provides for the sale of only those shares necessary to satisfy payment of applicable withholding taxes. (2) Termination of a trading plan that was intended to satisfy Rule 10b5-1(c).
Non-Rule 10b5-1 Arrangement Adopted |  | false
Non-Rule 10b5-1 Arrangement Terminated |  | false
Mauro Ferrari [Member] |  |
Trading Arrangements, by Individual |  |
Name | Mauro Ferrari |
Title | Board Member |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | 09/28/2023 |
Arrangement Duration |  | 20 days
Aggregate Available | 3,147 | 3,147
Douglass Given [Member] |  |
Trading Arrangements, by Individual |  |
Name | Douglass Given |
Title | Board Member |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | 09/26/2023 |
Arrangement Duration |  | 20 days
Aggregate Available | 2,911 | 2,911
Ken Myszkowski [Member] |  |
Trading Arrangements, by Individual |  |
Name | Ken Myszkowski |
Title | Chief Financial Officer |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | 09/07/2023 |
Arrangement Duration |  | 26 days
Aggregate Available | 30,000 | 30,000
Patrick O'Brien [Member] |  |
Trading Arrangements, by Individual |  |
Name | Patrick O’Brien |
Title | Chief Operating Officer and General Counsel |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | 09/03/2023 |
Arrangement Duration |  | 2 days
Aggregate Available | 4,000 | 4,000
Tracie Oliver [Member] |  |
Trading Arrangements, by Individual |  |
Name | Tracie Oliver |
Title | Chief Commercial Officer |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | 08/28/2023 |
Arrangement Duration |  | 208 days
Aggregate Available | 17,625 | 17,625
Victoria Vakiener [Member] |  |
Trading Arrangements, by Individual |  |
Name | Victoria Vakiener |
Title | Board Member |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | 09/28/2023 |
Arrangement Duration |  | 141 days
Aggregate Available | 6,519 | 6,519
William Waddill [Member] |  |
Trading Arrangements, by Individual |  |
Name | William Waddill |
Title | Board Member |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | 08/29/2023 |
Arrangement Duration |  | 20 days
Aggregate Available | 3,934 | 3,934
James Hamilton Terminated Plan [Member] | James Hamilton [Member] |  |
Trading Arrangements, by Individual |  |
Name | James Hamilton |
Title | Chief Discovery and Translational Medicine |
Rule 10b5-1 Arrangement Terminated | true |
Termination Date | 08/15/2023 |
Arrangement Duration |  | 28 days
Aggregate Available | 52,500 | 52,500
James Hamilton August 2023 Plan [Member] | James Hamilton [Member] |  |
Trading Arrangements, by Individual |  |
Name | James Hamilton |
Title | Chief Discovery and Translational Medicine |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | 08/22/2023 |
Arrangement Duration |  | 364 days
Aggregate Available | 35,000 | 35,000

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1 + Details
Name: | ecd_MtrlTermsOfTrdArrTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1 + Details
Name: | ecd_NonRule10b51ArrAdoptedFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1 + Details
Name: | ecd_NonRule10b51ArrTrmntdFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1 + Details
Name: | ecd_Rule10b51ArrAdoptedFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1 + Details
Name: | ecd_Rule10b51ArrTrmntdFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph A + Details
Name: | ecd_TradingArrByIndTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph B + Details
Name: | ecd_TrdArrAdoptionDate
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph C + Details
Name: | ecd_TrdArrDuration
Namespace Prefix: | ecd_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph A + Details
Name: | ecd_TrdArrIndName
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph A + Details
Name: | ecd_TrdArrIndTitle
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph D + Details
Name: | ecd_TrdArrSecuritiesAggAvailAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph B + Details
Name: | ecd_TrdArrTerminationDate
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ecd_IndividualAxis=arwr_MauroFerrariMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=arwr_DouglassGivenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=arwr_KenMyszkowskiMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=arwr_PatrickOBrienMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=arwr_TracieOliverMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=arwr_VictoriaVakienerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=arwr_WilliamWaddillMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_TradingArrAxis=arwr_JamesHamiltonTerminatedPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=arwr_JamesHamiltonMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_TradingArrAxis=arwr_JamesHamiltonAugust2023PlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |